135 related articles for article (PubMed ID: 22795922)
1. Diagnostic accuracy of 123 I-FP-CIT SPECT in diagnosing drug-induced parkinsonism: a prospective study.
Olivares Romero J; Arjona Padillo A
Neurologia; 2013 Jun; 28(5):276-82. PubMed ID: 22795922
[TBL] [Abstract][Full Text] [Related]
2. [¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism.
Tinazzi M; Cipriani A; Matinella A; Cannas A; Solla P; Nicoletti A; Zappia M; Morgante L; Morgante F; Pacchetti C; Sciarretta M; Dallocchio C; Rossi S; Malentacchi M; Ceravolo R; Frosini D; Sestini S; Bovi T; Barbui C
Schizophr Res; 2012 Aug; 139(1-3):40-5. PubMed ID: 22727453
[TBL] [Abstract][Full Text] [Related]
3. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
[TBL] [Abstract][Full Text] [Related]
4. Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy.
Benaderette S; Zanotti Fregonara P; Apartis E; Nguyen C; Trocello JM; Remy P; Devaux JY; Askienazy S; Vidailhet M
Mov Disord; 2006 Mar; 21(3):310-7. PubMed ID: 16211590
[TBL] [Abstract][Full Text] [Related]
5. [¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.
Brigo F; Matinella A; Erro R; Tinazzi M
Eur J Neurol; 2014 Nov; 21(11):1369-e90. PubMed ID: 24779862
[TBL] [Abstract][Full Text] [Related]
6. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson's disease using [(123)I]FP-CIT SPECT.
Huertas-Fernández I; García-Gómez FJ; García-Solís D; Benítez-Rivero S; Marín-Oyaga VA; Jesús S; Cáceres-Redondo MT; Lojo JA; Martín-Rodríguez JF; Carrillo F; Mir P
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):112-9. PubMed ID: 25120041
[TBL] [Abstract][Full Text] [Related]
7. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic accuracy of FP-CIT SPECT in the evaluation of patients with clinically uncertain parkinsonian syndrome].
Ortega Lozano SJ; Martínez del Valle Torres MD; Jiménez-Hoyuela García JM; Delgado García A; Molero Campos E; Campos Arillo V
Neurologia; 2007 Mar; 22(2):86-92. PubMed ID: 17323233
[TBL] [Abstract][Full Text] [Related]
9. Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism.
Mateos JJ; Lomeña F; Parellada E; Font M; Fernandez E; Pavia J; Prats A; Pons F; Bernardo M
Psychopharmacology (Berl); 2005 Sep; 181(2):401-6. PubMed ID: 15830229
[TBL] [Abstract][Full Text] [Related]
10. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
Zijlmans J; Evans A; Fontes F; Katzenschlager R; Gacinovic S; Lees AJ; Costa D
Mov Disord; 2007 Jul; 22(9):1278-85. PubMed ID: 17486613
[TBL] [Abstract][Full Text] [Related]
11. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
12. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
Hauser RA; Grosset DG
J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.
Shin HW; Kim JS; Oh M; You S; Kim YJ; Kim J; Kim MJ; Chung SJ
Neurol Sci; 2015 Feb; 36(2):269-74. PubMed ID: 25231645
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism].
Ortega Lozano SJ; Martínez Del Valle Torres MD; Jiménez-Hoyuela García JM; Gutiérrez Cardo AL; Campos Arillo V
Rev Esp Med Nucl; 2007; 26(5):277-85. PubMed ID: 17910836
[TBL] [Abstract][Full Text] [Related]
15. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
16. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
17. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
[TBL] [Abstract][Full Text] [Related]
18. FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up.
Hambÿe AS; Vervaet A; Dethy S
Nucl Med Commun; 2010 Jun; 31(6):583-9. PubMed ID: 20429096
[TBL] [Abstract][Full Text] [Related]
19. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
Jauković L; Ilić TV; Dopudja M; Ajdinović B
Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
